共 50 条
- [22] Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation [J]. FRONTIERS IN ONCOLOGY, 2022, 12
- [26] Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma [J]. INTERNATIONAL CANCER CONFERENCE JOURNAL, 2016, 5 (02): : 69 - 72
- [27] The role of brigatinib in crizotinib-resistant non-small cell lung cancer [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 123 - 130
- [28] Expression, purification, and structural studies of phospholamban mutants. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U431 - U431
- [30] Identification of a novel ALK variant intrinsically resistant to crizotinib [J]. CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2020, 2